NASDAQ:HRTH Harte Hanks (HRTH) Stock Price, News & Analysis → It's time to ween off Chinese lithium! (From Smallcaps Daily) (Ad) Free HRTH Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$7.20▼$7.3750-Day Range$7.37▼$8.9052-Week Range$2.23▼$8.90Volume14,342 shsAverage Volume9,785 shsMarket Capitalization$51.17 millionP/E Ratio4.52Dividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisCompetitorsHeadlinesTrendsStock AnalysisCompetitorsHeadlinesTrends Get Harte Hanks alerts: Email Address Ad Smallcaps DailyIt's time to ween off Chinese lithium!As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promising companies to be watching closelyLearn how this American company is leading the lithium-ion revolution About Harte Hanks Stock (NASDAQ:HRTH)Harte-Hanks, Inc. engages in the provision of marketing solutions. It specializes in consulting, data analytics, creative services, digital and social media, marketing strategy, marketing technology, and other related services. It supports a range of customers in the field of technology, travel and leisure, entertainment, pharmaceuticals, automotive, finance, and retail. The company was founded in 1923 and is headquartered in San Antonio, TX.Read More Ad Smallcaps DailyIt's time to ween off Chinese lithium!As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promising companies to be watching closelyLearn how this American company is leading the lithium-ion revolution HRTH Stock News HeadlinesMay 10, 2024 | msn.comHarte Hanks, Inc. (NASDAQ:HHS) Q1 2024 Earnings Call TranscriptMay 9, 2024 | markets.businessinsider.comHarte-Hanks is about to announce its earnings — here's what Wall Street expectsMay 6, 2024 | msn.comTom Hanks on his novel approach to moviesNovember 11, 2023 | benzinga.comHarte-Hanks Stock (NASDAQ:HHS) Earnings Dates and Earning CallsOctober 8, 2023 | yahoo.comTom Hanks Warns Fans About "AI Version of Me" Promoting Dental Plan | THR News VideoOctober 7, 2023 | abcnews.go.comTom Hanks warns fans about fake ad featuring fabricated image of his likenessAugust 2, 2023 | health.usnews.comDr. Elizabeth HanksAugust 2, 2023 | mirror.co.ukTom Hanks' son Chet Hanks cheekily grabs MMA fighter girlfriend's bum during racy workoutJuly 23, 2023 | msn.comHarte Hanks: Results Could Improve Soon, But Little Upside Right NowJune 20, 2023 | msn.comHarte Hanks names media industry veteran Kirk Davis as new CEOJune 19, 2023 | stockhouse.comIndustry-Veteran Kirk Davis Appointed New CEO at Harte HanksMarch 7, 2023 | msn.comHarte Hanks GAAP EPS of $2.70 beats by $2.60, revenue of $54.8M beats by $2.6MJanuary 31, 2023 | wsj.comHarte Hanks Chosen by Luxury Brand PIRCH to Lead New Direct Marketing CampaignsJanuary 3, 2023 | msn.comHarte-Hanks (HHS) Dips More Than Broader Markets: What You Should KnowAugust 26, 2022 | finance.yahoo.comWill Harte-Hanks (HHS) Gain on Rising Earnings Estimates?August 26, 2022 | finance.yahoo.comHere's Why Harte-Hanks (HHS) is a Great Momentum Stock to BuyAugust 13, 2022 | nasdaq.comWhat Kind Of Investors Own Most Of Harte Hanks, Inc. (NASDAQ:HHS)?May 24, 2022 | tmcnet.comHarte Hanks and Sony continue their winning tradition: receive two 2022 PDMA Benjamin Franklin AwardsMay 18, 2022 | markets.businessinsider.comHarte Hanks to Present at The LD Micro Invitational XIIMay 17, 2022 | finance.yahoo.comWhy Fast-paced Mover Harte-Hanks (HHS) Is a Great Choice for Value InvestorsJanuary 4, 2022 | markets.businessinsider.comHarte Hanks Hires Don Aicklen as Senior Vice President of Sales & MarketingNovember 18, 2021 | markets.businessinsider.comHere Is Why Bargain Hunters Would Love Fast-paced Mover Harte-Hanks (HRTH)November 17, 2021 | benzinga.comNotable Harte-Hanks Insider Makes $140K SaleNovember 17, 2021 | entrepreneur.comWhat Makes Harte-Hanks (HRTH) a Good Fit for "Trend Investing"November 15, 2021 | finance.yahoo.comHarte Hanks Hires Frank Sanni as Chief Strategy Officer for Marketing ServicesSee More Headlines Receive HRTH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Harte Hanks and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today6/10/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorBusiness Services Industry Direct Mail Advertising Services Sub-IndustryN/A Current SymbolNASDAQ:HRTH CUSIPN/A CIK45919 Webwww.hartehanks.com Phone(512) 434-1100Fax210-829-9139Employees2,434Year Founded1923Profitability EPS (Most Recent Fiscal Year)$1.62 Trailing P/E Ratio4.52 Forward P/E Ratio4.21 P/E GrowthN/ANet Income$-1,690,000.00 Net Margins7.17% Pretax Margin6.08% Return on Equity-10.71% Return on Assets4.37% Debt Debt-to-Equity RatioN/A Current Ratio1.95 Quick Ratio1.95 Sales & Book Value Annual Sales$176.90 million Price / Sales0.29 Cash FlowN/A Price / Cash FlowN/A Book Value($7.98) per share Price / Book-0.92Miscellaneous Outstanding Shares6,981,000Free Float5,460,000Market Cap$51.17 million OptionableNot Optionable Beta1.73 Social Links 10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesBrian LinscottChief Executive Officer & DirectorLaurilee KearnesChief Financial Officer & Vice PresidentElliott PetersonChief Technology OfficerGretchen RamseySVP & Head of StrategyKeith SedlakChief Growth OfficerKey CompetitorsMondeeNASDAQ:MONDGlory Star New Media GroupNASDAQ:GSMGHireQuestNASDAQ:HQILucas GCNASDAQ:LGCLQuest ResourceNASDAQ:QRHCView All Competitors HRTH Stock Analysis - Frequently Asked Questions What other stocks do shareholders of Harte Hanks own? Based on aggregate information from My MarketBeat watchlists, some companies that other Harte Hanks investors own include Pfizer (PFE), Advanced Micro Devices (AMD), Altimmune (ALT), Albireo Pharma (ALBO), Alliance Data Systems (ADS), AcelRx Pharmaceuticals (ACRX), Albertsons Companies (ACI), Achieve Life Sciences (ACHV), Barrick Gold (ABX) and Arbutus Biopharma (ABUS). This page (NASDAQ:HRTH) was last updated on 6/10/2024 by MarketBeat.com Staff From Our PartnersWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredIt's time to ween off Chinese lithium!As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promi...Smallcaps Daily | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredYou won't believe what Citigroup just did to it's depositorsThe FEDNOW Biden Dollar ends cash in a matter of WEEKS Stumbling Biden's dollar next phases begins Oct 21st...American Alternative | SponsoredRSVP: Charles Payne’s Cash Flow WorkshopDid you know you could "cash flow" the stocks in your portfolio? Without selling a single share of stock? ...Unstoppable Prosperity | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Harte Hanks, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Harte Hanks With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.